HCV J6/JFH1 Tilts the Capability of Myeloid-Derived Dendritic Cells to Favor the Induction of Immunosuppression and Th17-Related Inflammatory Cytokines

详细信息    查看全文

• 作者：Zhong Fang (1)
  Kai Zhu (1)
  Nining Guo (1)
  Na Zhang (1)
  Mo Guan (2)
  Chunfu Yang (1)
  Qinsong Pan (1)
  Ruicheng Wei (1)
  Chunhui Yang (1)
  Chaoyang Deng (1)
  Xiaoqing Liu (2)
  Ping Zhao (2)
  Qibin Leng (1)
  
  1. Key Laboratory of Molecular Virology and Immunology Institut Pasteur of Shanghai Shanghai Institutes for Biological Sciences ; Chinese Academy of Sciences ; 225 South Chongqing Road ; Shanghai ; China
  2. Department of Microbiology Shanghai Key Laboratory of Medical Biodefense ; Second Military Medical University ; Shanghai ; China
  
• 关键词：CD4+ T cells ; dendritic cells ; HCV ; IL ; 10 ; IL ; 17A ; Th17
• 刊名：Pharmaceutical Research
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：32
• 期：3
• 页码：741-748
• 全文大小：894 KB
• 参考文献：1. Hahn YS. Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion? Curr Opin Immunol. 2003;15:443鈥?. 3)00076-1" target="_blank" title="It opens in new window">CrossRef
  2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558鈥?7. 3-3099(05)70216-4" target="_blank" title="It opens in new window">CrossRef
  3. Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature. 2005;436:946鈥?2. 38/nature04079" target="_blank" title="It opens in new window">CrossRef
  4. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, / et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 2000;6:578鈥?2. 38/75063" target="_blank" title="It opens in new window">CrossRef
  5. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med. 2001;194:1395鈥?06. 395" target="_blank" title="It opens in new window">CrossRef
  6. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, / et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 1995;346:1006鈥?. 36(95)91691-1" target="_blank" title="It opens in new window">CrossRef
  7. Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, / et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology. 1999;117:933鈥?1. 353-7" target="_blank" title="It opens in new window">CrossRef
  8. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, / et al. HCV persistence and immune evasion in the absence of memory T cell help. Science. 2003;302:659鈥?2. CrossRef
  9. Shoukry NH, Cawthon AG, Walker CM. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol. 2004;58:391鈥?24. 30603.123836" target="_blank" title="It opens in new window">CrossRef
  10. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245鈥?2. 38/32588" target="_blank" title="It opens in new window">CrossRef
  11. Lee HK, Iwasaki A. Innate control of adaptive immunity: dendritic cells and beyond. Semin Immunol. 2007;19:48鈥?5. CrossRef
  12. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol. 2003;3:984鈥?3. 38/nri1246" target="_blank" title="It opens in new window">CrossRef
  13. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol. 2010;28:445鈥?9. 30409-101212" target="_blank" title="It opens in new window">CrossRef
  14. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621鈥?3. 31210-101400" target="_blank" title="It opens in new window">CrossRef
  15. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, / et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol. 1999;162:5584鈥?1.
  16. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology. 2001;120:512鈥?4. 3/gast.2001.21212" target="_blank" title="It opens in new window">CrossRef
  17. Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood. 2001;97:3171鈥?. 3171" target="_blank" title="It opens in new window">CrossRef
  18. Pachiadakis I, Pollara G, Chain BM, Naoumov NV. Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? Lancet Infect Dis. 2005;5:296鈥?04. 3-3099(05)70114-6" target="_blank" title="It opens in new window">CrossRef
  19. Waggoner SN, Hall CH, Hahn YS. HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production. J Leukoc Biol. 2007;82:1407鈥?9. CrossRef
  20. Zimmermann M, Flechsig C, La Monica N, Tripodi M, Adler G, Dikopoulos N. Hepatitis C virus core protein impairs / in vitro priming of specific T cell responses by dendritic cells and hepatocytes. J Hepatol. 2008;48:51鈥?0. CrossRef
  21. Eisen-Vandervelde AL, Waggoner SN, Yao ZQ, Cale EM, Hahn CS, Hahn YS. Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J Biol Chem. 2004;279:43479鈥?6. CrossRef
  22. Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, Romics Jr L, / et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol. 2003;170:5615鈥?4. CrossRef
  23. Ludwig IS, Lekkerkerker AN, Depla E, Bosman F, Musters RJ, Depraetere S, / et al. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J Virol. 2004;78:8322鈥?2. 322-8332.2004" target="_blank" title="It opens in new window">CrossRef
  24. Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A, Staropoli I, Foung S, Amara A, / et al. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem. 2003;278:20358鈥?6. 301284200" target="_blank" title="It opens in new window">CrossRef
  25. Liang H, Russell RS, Yonkers NL, McDonald D, Rodriguez B, Harding CV, / et al. Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells. J Virol. 2009;83:5693鈥?07. CrossRef
  26. Shiina M, Rehermann B. Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology. 2008;47:385鈥?5. CrossRef
  27. Tu Z, Hamalainen-Laanaya HK, Nishitani C, Kuroki Y, Crispe IN, Orloff MS. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation. Int Immunol. 2012;24:97鈥?06. 3/intimm/dxr104" target="_blank" title="It opens in new window">CrossRef
  28. Repnik U, Knezevic M, Jeras M. Simple and cost-effective isolation of monocytes from Buffy coats. J Immunol Methods. 2003;278:283鈥?2. 3)00231-X" target="_blank" title="It opens in new window">CrossRef
  29. Kato T, Date T, Murayama A, Morikawa K, Akazawa D, Wakita T. Cell culture and infection system for hepatitis C virus. Nat Protoc. 2006;1:2334鈥?. 38/nprot.2006.395" target="_blank" title="It opens in new window">CrossRef
  30. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, / et al. Complete replication of hepatitis C virus in cell culture. Science. 2005;309:623鈥?. CrossRef
  31. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693鈥?33. 32641" target="_blank" title="It opens in new window">CrossRef
  32. Basha HI, Subramanian V, Seetharam A, Nath DS, Ramachandran S, Anderson CD, / et al. Characterization of HCV-specific CD4 + Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis. Am J Transplant. 2011;11:775鈥?5. 3.2011.03458.x" target="_blank" title="It opens in new window">CrossRef
  33. Foster RG, Golden-Mason L, Rutebemberwa A, Rosen HR. Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection. Dig Dis Sci. 2012;57:381鈥?. CrossRef
  34. Grafmueller S, Billerbeck E, Blum HE, Neumann-Haefelin C, Thimme R. Differential antigen specificity of hepatitis C virus-specific interleukin 17- and interferon gamma-producing CD8(+) T cells during chronic infection. J Infect Dis. 2012;205:1142鈥?. 3/infdis/jis018" target="_blank" title="It opens in new window">CrossRef
  35. Seetharam AB, Borg BB, Subramanian V, Chapman WC, Crippin JS, Mohanakumar T. Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient. Transplantation. 2011;92:1364鈥?0. 3e31823817f5" target="_blank" title="It opens in new window">CrossRef
  36. Chang Q, Wang YK, Zhao Q, Wang CZ, Hu YZ, Wu BY. Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C. J Gastroenterol Hepatol. 2012;27:273鈥?. CrossRef
  37. Pepper M, Linehan JL, Pagan AJ, Zell T, Dileepan T, Cleary PP, / et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol. 2010;11:83鈥?. 38/ni.1826" target="_blank" title="It opens in new window">CrossRef
  38. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol. 1997;159:4772鈥?0.
  
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Biomedicine
  Pharmacology and Toxicology
  Pharmacy
  Biochemistry
  Medical Law
  Biomedical Engineering
  
• 出版者：Springer Netherlands
• ISSN：1573-904X

文摘